1C70 Feasibility Study - Trial NCT05628064
Access comprehensive clinical trial information for NCT05628064 through Pure Global AI's free database. This phase not specified trial is sponsored by Otto Bock Healthcare Products GmbH and is currently Not yet recruiting. The study focuses on Amputation. Target enrollment is 20 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Otto Bock Healthcare Products GmbH
Timeline & Enrollment
N/A
Nov 21, 2022
Jun 30, 2023
Primary Outcome
Extent of meeting amputees prosthetic foot needs: 1C70 vs everyday foot,Extent of meeting amputees prosthetic foot needs: 1C70 vs comparator foot,Change in patient-perceived mobility (PLUS-M) compared to baseline,Change in patient-perceived mobility (PLUS-M) compared to the comparator foot,Highest pain reported: 1C70 vs everyday foot,Highest pain reported: 1C70 vs comparator foot
Summary
The objective of this study is to characterize the extend of 1C70 meeting the amputees needs
 in comparison with their everyday and a comparator foot, in regards of daily activities,
 mobility and balance, as well as quality of life and pain.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05628064
Device Trial